{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T21:15:51Z","timestamp":1781298951358,"version":"3.54.1"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:00:00Z","timestamp":1493164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0176415","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T17:27:17Z","timestamp":1493227637000},"page":"e0176415","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML)"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0997-2725","authenticated-orcid":true,"given":"Ruth","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bellenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hoepner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisa","family":"Ellrichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiden","family":"Haghikia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,4,26]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1473-3099(09)70226-9","article-title":"Progressive multifocal leukoencephalopathy in HIV-1 infection","volume":"9","author":"P Cinque","year":"2009","journal-title":"The Lancet Infectious diseases"},{"issue":"2","key":"ref2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1001\/jamaneurol.2013.598","article-title":"Natalizumab: bench to bedside and beyond","volume":"70","author":"R Rudick","year":"2013","journal-title":"JAMA neurology"},{"issue":"11","key":"ref3","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1056\/NEJMoa0810257","article-title":"Treatment of progressive multifocal leukoencephalopathy associated with natalizumab","volume":"361","author":"W Wenning","year":"2009","journal-title":"The New England journal of medicine"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"5876798","DOI":"10.1155\/2016\/5876798","article-title":"Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to Fingolimod","volume":"2016","author":"T Sinnecker","year":"2016","journal-title":"Case reports in neurological medicine"},{"issue":"4","key":"ref5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/2040622316653307","article-title":"Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy","volume":"7","author":"RA Linker","year":"2016","journal-title":"Therapeutic advances in chronic disease"},{"issue":"6","key":"ref6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s13365-015-0316-4","article-title":"Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy","volume":"21","author":"T Dong-Si","year":"2015","journal-title":"Journal of neurovirology"},{"issue":"20","key":"ref7","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1212\/WNL.0b013e31821a446b","article-title":"Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"76","author":"P Vermersch","year":"2011","journal-title":"Neurology"},{"issue":"10","key":"ref8","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1136\/jnnp-2013-304897","article-title":"Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients","volume":"84","author":"S Dahlhaus","year":"2013","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"issue":"6","key":"ref9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/1756285615602832","article-title":"Progressive multifocal leukoencephalopathy: current treatment options and future perspectives","volume":"8","author":"D Pavlovic","year":"2015","journal-title":"Ther Adv Neurol Disord"},{"issue":"5","key":"ref10","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1128\/AAC.01614-08","article-title":"Identification and characterization of mefloquine efficacy against JC virus in vitro","volume":"53","author":"M Brickelmaier","year":"2009","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"5700","key":"ref11","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1126\/science.1103492","article-title":"The human polyomavirus, JCV, uses serotonin receptors to infect cells","volume":"306","author":"GF Elphick","year":"2004","journal-title":"Science (New York, NY)"},{"issue":"2","key":"ref12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1602\/neurorx.2.2.197","article-title":"Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making","volume":"2","author":"A Lin","year":"2005","journal-title":"NeuroRx"},{"issue":"2","key":"ref13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00062-013-0216-z","article-title":"A case of natalizumab-associated progressive multifocal leukoencephalopathy-role for advanced MRI?","volume":"24","author":"M Berghoff","year":"2014","journal-title":"Clinical neuroradiology"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"415873","DOI":"10.1155\/2013\/415873","article-title":"Early magnetic resonance detection of natalizumab-related progressive multifocal leukoencephalopathy in a patient with multiple sclerosis","volume":"2013","author":"G Manenti","year":"2013","journal-title":"Case reports in radiology"},{"issue":"6","key":"ref15","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1212\/NXI.0000000000000171","article-title":"7T MRI in natalizumab-associated PML and ongoing MS disease activity: A case study","volume":"2","author":"T Sinnecker","year":"2015","journal-title":"Neurology(R) neuroimmunology & neuroinflammation"},{"issue":"4","key":"ref16","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1136\/jnnp.66.4.520","article-title":"Proton magnetic resonance spectroscopy pattern of progressive multifocal leukoencephalopathy in AIDS","volume":"66","author":"A Iranzo","year":"1999","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"issue":"10","key":"ref17","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1212\/WNL.0b013e318268465b","article-title":"Metabolic profile of PML lesions in patients with and without IRIS: an observational study","volume":"79","author":"S Gheuens","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"ref18","first-page":"224","article-title":"Neuropsychological impairment in natalizumab-associated progressive multifocal leukoencephalopathy: implications for early diagnosis","volume":"87","author":"R Hoepner","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref19","article-title":"Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy","author":"R Hoepner","year":"2016","journal-title":"Multiple sclerosis (Houndmills, Basingstoke, England)"},{"issue":"15","key":"ref20","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","article-title":"PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section","volume":"80","author":"JR Berger","year":"2013","journal-title":"Neurology"},{"issue":"11","key":"ref21","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"JF Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"ref22","first-page":"191","article-title":"The clinical evaluation of chemotherapeutic agents in cancer","author":"D Karnofsky","year":"1949"},{"issue":"8","key":"ref23","doi-asserted-by":"publisher","first-page":"E156","DOI":"10.3174\/ajnr.A2305","article-title":"Proton MR spectroscopy in a 1T open MR imaging system","volume":"32","author":"CG Filippi","year":"2011","journal-title":"AJNR American journal of neuroradiology"},{"issue":"1","key":"ref24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11547-009-0408-4","article-title":"Computation of brain metabolite ratios in single-voxel proton MR spectroscopy: comparison between semiautomatic and automatic software","volume":"115","author":"LN Mazzoni","year":"2010","journal-title":"La Radiologia medica"},{"issue":"Suppl 1","key":"ref25","doi-asserted-by":"publisher","first-page":"31S","DOI":"10.1111\/j.1552-6569.2007.00134.x","article-title":"MR spectroscopy in multiple sclerosis","volume":"17","author":"N De Stefano","year":"2007","journal-title":"J Neuroimaging"},{"issue":"3","key":"ref26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/00019052-200206000-00004","article-title":"Magnetic resonance spectroscopy in multiple sclerosis: window into the diseased brain","volume":"15","author":"JS Wolinsky","year":"2002","journal-title":"Current opinion in neurology"},{"issue":"1","key":"ref27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1148\/radiol.2341031895","article-title":"Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience","volume":"234","author":"J He","year":"2005","journal-title":"Radiology"},{"issue":"18","key":"ref28","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1212\/WNL.0b013e318253d61e","article-title":"Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS","volume":"78","author":"S Gheuens","year":"2012","journal-title":"Neurology"},{"issue":"3","key":"ref29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/197140091002300302","article-title":"Lipid Resonance on In Vivo Proton MR Spectroscopy: Value of Other Metabolites in Differential Diagnosis","volume":"23","author":"S Mohan","year":"2010","journal-title":"The neuroradiology journal"},{"issue":"2","key":"ref30","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1006\/immu.1994.1019","article-title":"1H magnetic resonance spectroscopy of primary human and murine cells of the myeloid lineage","volume":"4","author":"NJ King","year":"1994","journal-title":"ImmunoMethods"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/nbm.1661","article-title":"MR-visible lipids and the tumor microenvironment","volume":"24","author":"EJ Delikatny","year":"2011","journal-title":"NMR in biomedicine"},{"issue":"2","key":"ref32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1006\/immu.1994.1014","article-title":"Two-dimensional 1H NMR studies of membrane changes during the activation of primary T lymphocytes","volume":"4","author":"AJ Dingley","year":"1994","journal-title":"ImmunoMethods"},{"issue":"1\u20132","key":"ref33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jns.2005.03.018","article-title":"Magnetic resonance spectroscopy as a measure of brain damage in multiple sclerosis","volume":"233","author":"N De Stefano","year":"2005","journal-title":"Journal of the neurological sciences"},{"issue":"8845","key":"ref34","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/0140-6736(93)90391-S","article-title":"Magnetic resonance spectroscopy of multiple sclerosis: in-vivo detection of myelin breakdown products","volume":"341","author":"RA Koopmans","year":"1993","journal-title":"Lancet (London, England)"},{"issue":"2","key":"ref35","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1148\/radiol.2016151654","article-title":"Metabolic Patterns in Chronic Multiple Sclerosis Lesions and Normal-appearing White Matter: Intraindividual Comparison by Using 2D MR Spectroscopic Imaging","volume":"281","author":"V Fleischer","year":"2016","journal-title":"Radiology"},{"issue":"6","key":"ref36","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/1756285614556287","article-title":"Rituximab postprogressive multifocal leukoencephalopathy: a Feasible therapeutic option in selected cases","volume":"7","author":"R Hoepner","year":"2014","journal-title":"Ther Adv Neurol Disord"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0176415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T20:06:29Z","timestamp":1719173189000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0176415"}},"subtitle":[],"editor":[{"given":"Christoph","family":"Kleinschnitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,4,26]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0176415","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,26]]}}}